Lobe Sciences Ltd. (CSE: LOBE)
Canada
· Delayed Price · Currency is CAD 0.0200
-0.0100 (-33.33%)
Jan 20, 2025, 12:53 PM EST
Lobe Sciences Company Description
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.
The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020.
Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.
Lobe Sciences Ltd.
| Country | Canada |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Frederick Sancilio |
Contact Details
Address: 1771 Robson Street Vancouver, British Columbia V6G 3B7 Canada | |
| Phone | 949-505-5623 |
| Website | lobesciences.com |
Stock Details
| Ticker Symbol | LOBE |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA53946V2066 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Frederick Dominick Sancilio M.S., Ph.D. | Chairman and Chief Executive Officer |
| Mathew Lee C.A., CPA | Chief Financial Officer |
| Maghsoud Dariani | Chief Science Officer |